Mirum Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 159.9M | 148.9M | 133.0M | 127.8M | 111.6M | 99.4M | 90.4M | 77.9M |
| Cost of Goods Sold | 28.9M | 28.3M | 25.5M | 23.4M | 23.0M | 22.8M | 20.8M | 20.2M |
| Gross Profit | 131.0M | 120.6M | 107.5M | 104.4M | 88.6M | 76.6M | 69.6M | 57.6M |
| R&D Expenses | 97.9M | 51.1M | 43.0M | 46.1M | 46.0M | 44.0M | 31.7M | 32.7M |
| Operating Expenses | 194.2M | 125.2M | 104.9M | 109.4M | 103.8M | 100.9M | 82.3M | 81.9M |
| Operating Income | -63.2M | -4.6M | 2.6M | -5.0M | -15.2M | -24.2M | -12.7M | -24.2M |
| Other Income / Gains | -726.5M | -396K | 40K | -470K | 1.5M | -144K | -1.2M | 229K |
| Net Income | -790.2M | -5.7M | 2.9M | -5.9M | -14.7M | -23.8M | -14.2M | -24.6M |
| EPS (Diluted) | -13.43 | -0.12 | 0.057 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.819 | 0.81 | 0.808 | 0.817 | 0.794 | 0.771 | 0.77 | 0.74 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41.2M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.0M |
| Selling General And Administrative Expenses | 96.3M | 74.1M | 61.9M | 63.3M | 57.7M | 56.8M | 50.5M | 49.2M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 223.0M | 153.5M | 130.4M | 132.8M | 126.8M | 123.6M | 103.1M | 102.1M |
| Interest Income | 3.4M | 3.4M | 3.3M | 3.0M | 3.0M | 3.2M | 3.5M | 3.5M |
| Interest Expense | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M | 3.6M |
| Depreciation And Amortization | 6.9M | 6.1M | 6.1M | 6.1M | 6.1M | 6.1M | 6.1M | 5.9M |
| Ebitda | -56.3M | 4.7M | 9.1M | 4.2M | -4.0M | -14.7M | -4.2M | -14.6M |
| Ebitdaratio | -0.352 | 0.032 | 0.068 | 0.033 | -0.036 | -0.148 | -0.047 | -0.187 |
| Operating Income Ratio | -0.395 | -0.031 | 0.02 | -0.039 | -0.136 | -0.244 | -0.14 | -0.311 |
| Income Before Tax | -789.7M | -5.0M | 2.6M | -5.5M | -13.6M | -24.4M | -13.9M | -24.0M |
| Income Before Tax Ratio | -4.939 | -0.033 | 0.02 | -0.043 | -0.122 | -0.245 | -0.154 | -0.308 |
| Income Tax Expense | 475K | 767K | -262K | 402K | 1.0M | -576K | 347K | 635K |
| Net Income Ratio | -4.942 | -0.038 | 0.022 | -0.046 | -0.132 | -0.239 | -0.158 | -0.316 |
| Epsdiluted | -13.43 | -0.12 | 0.051 | -0.12 | -0.30 | -0.49 | -0.30 | -0.52 |
| Weighted Average Shs Out | 58.9M | 50.2M | 58.1M | 49.7M | 48.9M | 48.3M | 47.8M | 47.2M |
| Weighted Average Shs Out Dil | 58.9M | 50.2M | 57.0M | 49.7M | 48.9M | 48.3M | 47.8M | 47.2M |